In the News
Articles represent the views of their authors and not necessarily those of ME/CFS Australia. Some links lead to articles on third party websites.
International ME/CFS Conference Roundup: Setbacks And New Hopes For Therapeutic Research
At the Berlin event, researchers presented initial results of new clinical trials. All of the controlled trials presented for the first time at the conference failed to meet goals.
How A Real-Life Health Issue Led To One Of The Most Iconic Episodes Of The Golden Girls
"The episode was my way of getting back at all the doctors who didn’t believe me."
Congratulations Dr. Melissa Johnson!
Congratulations to Canada's University of Waterloo's newest PhD graduate, Dr. Melissa Johnson, who successfully defended her dissertation, "A 'Chronic Complainer’s' Guide to the Hystericizing of Fibromyalgia."
Chronic Illness Linked To Hardship – Study
People living with chronic fatigue in Aotearoa New Zealand face substantial health challenges, limited access to support, and long-term economic hardship, a new University of Otago – Ōtākou Whakaihu Waka-led study has found.
Low-Dose Ketamine Shows Promise For Easing Chronic Fatigue
A single, low-dose intravenous infusion of ketamine reduced symptoms of chronic fatigue in patients suffering from various medical conditions, though the results were not statistically significant when compared to another sedative. The trial offers early evidence that ketamine and similar drugs might act quickly to relieve severe fatigue, paving the way for larger clinical trials in the future. The findings were published in Pharmacological Reports.
'I Kept Crashing After The School Run And Taking Time Off Work. Then Doctors Said Three Words.'
An article by Australian ME/CFS sufferer Melissa Cashman.
Virax Biolabs Reports Positive Early Clinical Data For ViraxImmune™ In Long COVID And Related Post-Acute Infection Syndromes
LONDON, May 26, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today reported positive early pilot performance data for ViraxImmune™, its blood-based test in development for Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome ("ME/CFS") and related post-acute infection syndromes ("PAIS"). In the pilot dataset, ViraxImmune™ demonstrated measurable separation between PAIS patients and healthy controls, achieving 88% specificity and 92% positive predictive value ("PPV") — early performance metrics that Virax believes support continued development and advancement into larger clinical validation.
BBC Gardeners' World's Adam Frost Opens Up On Chronic Disease That Affects 2.5m In UK
BBC Gardeners' World presenter Adam Frost has opened up about living with Fibromyalgia, revealing how therapeutic gardening and plants help him manage the chronic pain condition.
Mold Exposure Can Trigger And Worsen Chronic Illness. Climate Change Will Increase The Risk.
Flooding from severe weather events will increase the risk of water damage and mold growth in buildings. Mold exposure could play a role in Long COVID and ME, but more research is needed to understand its health impacts.
Sussex ME Charity Marks 40 Years During Awareness Week
A UK charity supporting people living with ME is marking its 40th anniversary during ME Awareness Week.
'The Symptoms I Experienced Before Devastating ME Diagnosis Changed My Life Forever'
A profile of Scottish ME/CFS sufferer Tanya Fourie.
Beyond Tired
Chronic Fatigue Syndrome is about more than just being tired. Editor Melissa Holmes speaks to Isabelle Pearcey about living with the condition.